Literature DB >> 6417707

Regional distribution of sultopride and sulpiride in rat brain measured by radioimmunoassay.

A Mizuchi, N Kitagawa, Y Miyachi.   

Abstract

Sensitive and specific radioimmunoassays for both sultopride and sulpiride were developed. Using these radioimmunoassays, the regional distributions of sultopride and sulpiride in rat brain after intraperitoneal administration were investigated. Although relatively small amounts of both drugs were detected in the brain, sultopride appears to pass the blood-brain barrier more easily than sulpiride. Relatively high concentrations of sultopride were seen in hypothalamus, striatum, the mesolimbic area and hippocampus, while sulpiride accumulated mainly in brain areas such as hypothalamus, medulla oblongata and cerebellum, where the blood-brain barrier is less effective. Both drugs seem to be concentrated by the pituitary and pineal body. These differences between sultopride and sulpiride in penetration to the brain may depend on their different lipid solubilities, since sultopride has a higher lipid solubility compared with sulpiride.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417707     DOI: 10.1007/BF00427261

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.

Authors:  P Jenner; P N Elliott; A Clow; C Reavill; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1978-01       Impact factor: 3.765

2.  Atropine manipulation of elevated cerebral dopamine turnover caused by haloperidol or substituted benzamide drugs.

Authors:  P N Elliott; P Jenner; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1978-12       Impact factor: 3.765

3.  Assessment of the neuroleptic potential of some novel benzamide, butyrophenone, phenothiazine and indole derivatives.

Authors:  B Costall; W H Funderburk; C A Leonard; R J Naylor
Journal:  J Pharm Pharmacol       Date:  1978-12       Impact factor: 3.765

4.  Statistical quality control of radioimmunoassays.

Authors:  D Rodbard; P L Rayford; J A Cooper; G T Ross
Journal:  J Clin Endocrinol Metab       Date:  1968-10       Impact factor: 5.958

5.  Substituted benzamides as cerebral dopamine antagonists in rodents.

Authors:  P N Elliott; P Jenner; G Huizing; C D Marsden; R Miller
Journal:  Neuropharmacology       Date:  1977-05       Impact factor: 5.250

6.  Effects of two substituted benzamides, tiapride and sultopride, on gonadotrophins and prolactin.

Authors:  M L'Hermite; R M MacLeod; C Robyn
Journal:  Acta Endocrinol (Copenh)       Date:  1978-09

7.  Development of radioimmunoassay for sultopride and sulpiride.

Authors:  A Mizuchi; S Saruta; N Kitagawa; Y Miyachi
Journal:  Arch Int Pharmacodyn Ther       Date:  1981-12

8.  Acute and chronic effects of sulpride on serum prolactin and gonadotropin levels in castrated male rats (38581).

Authors:  L Debeljuk; R Rozados; H Daskal; V Velez; A M Mancini
Journal:  Proc Soc Exp Biol Med       Date:  1975-02

9.  Characteristics of [3H]sultopride binding to rat brain.

Authors:  A Mizuchi; N Kitagawa; S Saruta; Y Miyachi
Journal:  Eur J Pharmacol       Date:  1982-10-15       Impact factor: 4.432

10.  Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations.

Authors:  A E Theodorou; M D Hall; P Jenner; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1980-06       Impact factor: 3.765

View more
  7 in total

1.  The effects of dopamine D1 and D2 receptor antagonists on the rewarding effects of delta 1 and delta 2 opioid receptor agonists in mice.

Authors:  T Suzuki; M Tsuji; T Mori; M Misawa; H Nagase
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

2.  Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.

Authors:  M Vasse; P Protais; J Costentin; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

3.  Impact of D2 receptor internalization on binding affinity of neuroimaging radiotracers.

Authors:  Ningning Guo; Wen Guo; Michaela Kralikova; Man Jiang; Ira Schieren; Raj Narendran; Mark Slifstein; Anissa Abi-Dargham; Marc Laruelle; Jonathan A Javitch; Stephen Rayport
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

Review 4.  Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Authors:  Peter M Haddad; Angelika Wieck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.

Authors:  Rodrigo A Bressan; Kjell Erlandsson; Edgar P Spencer; Peter J Ell; Lyn S Pilowsky
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

6.  Differences in effects of sultopride and sulpiride on dopamine turnover in rat brain.

Authors:  K Moriuchi; Y Imazu; H Yoneda
Journal:  Neurochem Res       Date:  1995-01       Impact factor: 3.996

7.  The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide.

Authors:  F Brown; W Campbell; M S Clark; D S Graves; M S Hadley; J Hatcher; P Mitchell; P Needham; G Riley; J Semple
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.